Aurum Biosciences Ltd Revenue and Competitors
Employee Data
- Aurum Biosciences Ltd has 5 Employees.
- Aurum Biosciences Ltd grew their employee count by -17% last year.
Aurum Biosciences Ltd's People
| Name | Title | Email/Phone |
|---|
Aurum Biosciences Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 680 | 30% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5095 | 12% | N/A | N/A |
What Is Aurum Biosciences Ltd?
Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia.\n\nPreclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.
keywords:N/A
N/A
Total Funding
5
Number of Employees
N/A
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Glasgow
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 5 | 67% | N/A |
#2 | $0.1M | 5 | 25% | N/A |
#3 | N/A | 5 | 150% | N/A |
#4 | N/A | 5 | -17% | N/A |
#5 | $0.5M | 7 | -12% | N/A |